Who invested in Ractigen Therapeutics?
Ractigen Therapeutics's investors include Isai and SDIC Venture Capital.
Who invested in Ractigen Therapeutics
Funding summaryUpdated 26 Oct 2026
$30Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $30MJan 2022
- Investors
- 2
The rounds
- Jan 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ractigen Therapeutics
How much has Ractigen Therapeutics raised?
Ractigen Therapeutics has raised $30M across 1 round since 2022.
When did Ractigen Therapeutics last raise?
Ractigen Therapeutics's most recent round was a Series A of $30M in Jan 2022.
What was Ractigen Therapeutics's biggest round?
Its most recent round, $30M in Jan 2022, is also its largest on record.
Who backed Ractigen Therapeutics first?
Ractigen Therapeutics's first round on record, in Jan 2022, was backed by Isai and SDIC Venture Capital.
What stage is Ractigen Therapeutics at?
Ractigen Therapeutics's latest named round is a Series A, in Jan 2022.
Companies like Ractigen Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.